Phosphodiesterase inhibition and Ca2+ sensitization

被引:0
|
作者
Ravens, U [1 ]
Himmel, HM [1 ]
Fluss, M [1 ]
Davia, K [1 ]
Harding, SE [1 ]
机构
[1] NATL HEART & LUNG INST,DEPT CARDIAC MED,LONDON SW3 6LY,ENGLAND
关键词
thiadiazone derivatives; stereoselectivity; positive inotropic effect; action potential duration; delayed rectifier K+ current; human ventricular myocytes;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Inhibitors of phosphodiesterase type III (PDE III) enhance cardiac contractile force by elevating the intracellular calcium concentration [Ca2+](i) by impairing cAMP degradation thus increasing cAMP levels. The drugs are more effective in healthy than in failing hearts since basal cAMP production is diminished in the latter. However, long term treatment with PDE-III inhibitors does not appear to be beneficial due to increased risk of potentially lethal arrhythmias caused by augmentation of [Ca2+](i) [1). This risk should be absent in Ca2+ sensitizers. Recently, thiadiazinone derivatives have been synthetized in which the potency for Ca2+ sensitization is many-fold larger than the potency for PDE-III inhibition. The Ca2+-sensitizing action resides in the [+]-enantiomers, while the [-]-enantiomers show weak PDE-III inhibition. In the enantiomer pair [+]-EMD 60263 and [-]-EMD 60264, only the former concentration-dependently increased force of contraction in isolated cardiac preparations and myocytes. In the Langendorff-perfused guinea-pig heart, force was reversibly increased, whereas [-]-EMD 60264 even produced a negative inotropic response despite of its PDE inhibitory activity. Heart rate, however, was reduced by both enantiomers. Perfusion pressure remained unaffected. The effects were fully reversible upon wash-out of the enantiomers. [+]-EMD 60263 also enhanced cell shortening of human myocytes from both normal and failing hearts. In contrast to the opposite effects on contractility, both enantiomers prolong the action potential duration by blocking the rapidly activating component of the delayed rectifier K+ current. Thus they also possess class III antiarrhythmic activity. The therapeutic potential of these agents has yet to be assessed in clinical studies.
引用
收藏
页码:245 / 249
页数:5
相关论文
共 50 条
  • [1] Photolysis of the novel inotropes EMD 57033 and EMD 57439: Evidence that Ca2+ sensitization and phosphodiesterase inhibition depend upon the same enantiomeric site
    Lee, JA
    Palmer, S
    Kentish, JC
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (08) : 2037 - 2044
  • [2] Sensitization of the Ca2+ release channel (ryanodine receptor) to Ca2+ activation by ryanodine
    Chen, SRW
    Li, P
    Zhang, L
    [J]. BIOPHYSICAL JOURNAL, 2001, 80 (01) : 384A - 384A
  • [3] Ca2+ dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle
    Dimopoulos, George J.
    Semba, Shingo
    Kitazawa, Kazuyo
    Eto, Masumi
    Kitazawa, Toshio
    [J]. CIRCULATION RESEARCH, 2007, 100 (01) : 121 - 129
  • [4] New roads leading to Ca2+ sensitization
    Somlyo, AV
    [J]. CIRCULATION RESEARCH, 2002, 91 (02) : 83 - 84
  • [5] Myofilament Ca2+ sensitization and cardiac arrhythmia
    Chen, Peng-Sheng
    [J]. HEART RHYTHM, 2009, 6 (02) : 292 - 292
  • [6] INHIBITION OF CA2+ ENTRY BY CA2+ OVERLOADING OF INTRACELLULAR CA2+ STORES IN HUMAN PLATELETS
    KIMURA, M
    CHO, JH
    REEVES, JP
    AVIV, A
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1994, 479 (01): : 1 - 10
  • [7] The insulinotropic mechanism of the novel hypoglycaemic agent JTT-608:: direct enhancement of Ca2+ efficacy and increase of Ca2+ influx by phosphodiesterase inhibition
    Mukai, E
    Ishida, H
    Fujimoto, S
    Kajikawa, M
    Okamoto, Y
    Fujita, J
    Hamamoto, Y
    Tsuura, Y
    Yamada, Y
    Furukawa, N
    Ohta, T
    Seino, Y
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (05) : 901 - 908
  • [8] Mitochondrial Ca2+ Uptake; Regulation by Ca2+, Inhibition by Minocyclin
    Csordas, Gyoergy
    Golenar, Tuende
    Hajnoczky, Gyoergy
    [J]. BIOPHYSICAL JOURNAL, 2011, 100 (03) : 44 - 44
  • [9] The insulinotropic mechanism of the novel hypoglycemic agent, JTT-608:: Direct enhancement of Ca2+ efficacy with increase of Ca2+ influx by phosphodiesterase inhibition
    Mukai, E
    Ishida, H
    Fujimoto, S
    Furukawa, N
    Ohta, T
    Yamada, Y
    Seino, Y
    [J]. DIABETES, 1999, 48 : A243 - A243
  • [10] Conceptualizing conduction as a pliant vasomotor response: impact of Ca2+ fluxes and Ca2+ sensitization
    Hald, Bjorn Olav
    Welsh, Donald G.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2020, 319 (06): : H1290 - H1301